Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health and Care Excellence (NICE) has launched a new online learning tool – Severe mental illness: prescribing and monitoring antipsychotics.

Developed by the Centre for Pharmacy Postgraduate Education (CPPE), the tool supports the implementation of:

  • NICE clinical guideline 155, Psychosis and schizophrenia in children and young people: recognition and management
  • NICE clinical guideline 178: Psychosis and schizophrenia in adults: treatment and management
  • NICE clinical guideline 185: Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care.


We hope that healthcare professionals involved in the care of people with psychosis, schizophrenia or bipolar disorder will access our latest online learning tool, 'Severe mental illness: prescribing and monitoring antipsychotics'.

- Ceinwen Mannall, Lead Pharmacist, Learning Development, CPPE

The tool uses interactive activities and audio to support the recognition, management and monitoring of children, young people and adults with severe mental illness.

The tool offers advice on recognising, treating and monitoring patients with severe mental illness, with a particular focus on the use and monitoring of antipsychotic medicines.

This free tool supports some of the guidelines’ key recommendations and is available from the learning and professional development section of the NICE website here.

Sign-up for our newsletter

Keep up-to-date with the latest news, events and publications.